PharmaBoardroom

5 Top European Mid-Cap CEOs To Know

Bringing together insights from the heads of some of Europe's most prominent mid-cap pharma firms. The leaders of Ipsen, Genmab, Pierre Fabre, Esteve…

Marc Comas – Managing Director, Accord Healthcare Iberia

Marc Comas, managing director of Accord Healthcare Iberia, highlights the footprint of the company as the leading generics and biosimilars player in…

Philippe Archinard – CEO, Transgene, France

Phillipe Archinard CEO of Transgene shares insights on the latest technologies being developed by the gene therapy specialist, explains how France’s…

AI in Clinical Trials: Improving Efficiency, Reducing Costs

Paul Bleicher, CEO at OptumLabs, and one of the speakers at the FT US Pharma & Biotech Summit on May 14, shares insights on the benefits we will…

William (Wei) Cao – Founder, Chairman & CEO, Gracell,…

William Wei Cao, chairman and CEO of Gracell, shares the fascinating journey that inspired him to establish Gracell in Shanghai to tackle the four big…

USA: The Biosimilars Trade Opportunity

Chip Davis of the Association for Accessible Medicines argues for greater provision for access to affordable medicines – including biosimilars –…

André Choulika – Chairman & CEO, Cellectis, France

André Choulika, Chairman and CEO of Cellectis, discusses how UCART will revolutionize cell therapy as a universal gene-edited solution as opposed to…

Elie Lobel – CEO, Orange Healthcare, France

Elie Lobel, CEO of Orange Healthcare, explains how digitalization is bringing together stakeholders from across the healthcare continuum, allowing…

Vincent Pont – President, Laboratoire Arrow, France

Vincent Pont, president of Laboratoire Arrow, explains the company’s history, its collaboration with Aurobindo, the Indian generic pharmaceuticals…

Bertrand de Lavenne – General Manager, Mylan France

Bertrand de Lavenne, general manager of Mylan France, explains how the affiliate is positioned within the group’s operations and how the Mylan…

Christophe Lala – General Manager Western Europe, GE…

Christophe Lala, general manager of western Europe for GE Healthcare offers an overview of the current dynamics impacting the French healthcare…

The End of Free Sale of CBD Products in Europe?

Peter Homberg of Dentons Germany examines the regulatory status quo around the free sale of products containing cannabidiol (CBD) across Europe.…

Tagged with GE